Holen Sie sich die Stockscreener-App
186.88
0.16%
-0.1441
Schlusskurs vom Vortag:
$187.02
Offen:
$189.12
24-Stunden-Volumen:
764
Relative Volume:
0.11
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-1.16%
1M Leistung:
-4.30%
6M Leistung:
+12.68%
1J Leistung:
+15.94%
1-Tages-Spanne:
$188.13
$189.12
1-Wochen-Bereich:
$187.02
$194.24
52-Wochen-Spanne:
$135.34
$202.91
Vaneck Biotech Etf Stock (BBH) Company Profile
Firmenname
Vaneck Biotech Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare BBH vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BBH
Vaneck Biotech Etf
|
188.13 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
327.28 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
State Street Spdr S P 500 Etf Trust
|
664.82 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
667.81 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
260.72 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
595.42 | 124.43B | 0 | 0 | 0 | 0.00 |
Vaneck Biotech Etf Aktie (BBH) Neueste Nachrichten
Vertex's New Kidney Drug Delivers Big Trial Win, Stock Jumps - Bitget
Why Is Vertex Pharmaceuticals Stock Soaring Tuesday?Vertex Pharmaceuticals (NASDAQ:VRTX) - Benzinga
Is Investing in the VanEck Biotech ETF (BBH) a Good Choice? - Bitget
Should You Invest in the VanEck Biotech ETF (BBH)? - Yahoo Finance Singapore
Should You Consider Putting Money into the VanEck Biotech ETF (BBH)? - Bitget
How to Buy iShares Biotechnology ETF (IBB) - The Motley Fool
How to Invest in VanEck Biotech ETF (BBH) - The Motley Fool
True Market-Cap Exposure to Communication Services - VanEck
The top performing pharma and biotech stocks as group sees resurgence (PJP:NYSEARCA) - Seeking Alpha
7 Best Biotech ETFs to Buy Now | Investing | U.S. News - US News Money
How AI Is Reshaping Drug Discovery and Healthcare Investing - VanEck
How AI Is Reshaping Drug Discovery And Healthcare Investing - Seeking Alpha
Best Biotech ETFs to Buy in 2026 - The Motley Fool
Where To Invest $100,000: Japan Stocks, AI, Baseball Cards - Bloomberg.com
Moderna’s rally ripples through biotech and health care ETFs - MSN
BBH: Mature Biotech Exposure, But Limited Growth Ahead (NASDAQ:BBH) - Seeking Alpha
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
December Market Recap: Innovation Matures, Constraints Tighten, Money Evolves - VanEck
Precious Metals Define Commodity Performance in 2025 - VanEck
IYH: Elevated Valuations And Slowing Growth Signal Subpar 2026 Returns - Seeking Alpha
Why VanEck Morningstar International Moat ETF stock is upgraded to buyJuly 2025 Macro Moves & Free Community Consensus Stock Picks - ulpravda.ru
As Gold Soars, Opportunity Lies in ‘Better, Not Bigger’ Mining Acquisitions - VanEck
Short Interest in VanEck Biotech ETF (NASDAQ:BBH) Decreases By 16.5% - Defense World
How to Buy Gilead Sciences Stock (GILD) - The Motley Fool
Biogen: Competing With Eli Lilly's Kisunla, Safety Gives Market Edge (NASDAQ:BIIB) - Seeking Alpha
VanEck Biotech ETF declares annual distribution of $0.9565 - MSN
3 ASX ETFs to target in the new year – the booming themes of 2025 - The Motley Fool Australia
Day by day downgrades VanEck ETF TrustVanEck Biotech ETF (BBH) - MSN
Can Amgen Sustain Its Rally In 2026 (NASDAQ:AMGN) - Seeking Alpha
Why Are Investors Re-Evaluating Large Pharmaceutical Companies? - VanEck
Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus - Sahm
VanEck Mid-December 2025 Bitcoin ChainCheck - VanEck
VanEck Announces Year-End Distributions for VanEck Equity ETFs - Crypto Reporter
Plan for 2026: Predictions from Our Portfolio Managers - VanEck
The Next Phase of Retail: How Consumer Behavior and Technology Are Shaping the Industry - VanEck
Defense Start-ups Galvanize a Once Sleepy Sector - VanEck
5 Best ETFs for Tax-Loss Harvesting | Investing | U.S. News - US News Money
November Market Recap: AI Adoption Surges & Tight Liquidity Creates Opportunity - VanEck
The Fed cut interest rates and bought short-term bonds, Powell leaned dovish, US stocks, short-term US bonds, and gold rose, the dollar fell, while Bitcoin fluctuated. - 富途牛牛
Biotech may still have life - Investment Executive
EDGAR Filing Documents for 0000930413-25-003577 - SEC.gov
How Much More Tightening in EM? - VanEck
Inflation Persistence in EM - VanEck
Yield Advantage: Why EM Local Bonds Are Leading DM Bonds in 2025 - VanEck
Chinese Bonds Offer Yield Pickup - VanEck
AI Revolutionizes Pharma and Biotech Sectors: Market Trends for 2025 - Blockchain News
EM High Yield Corporates: Superior Yields, Low Defaults - VanEck
How India’s Digital Economy Compares to China - VanEck
InflationDownside Surprises Stage Comeback - VanEck
Higher for LongerMarket Not So Sure - VanEck
Global Pressures – Pick a Direction - VanEck
Finanzdaten der Vaneck Biotech Etf-Aktie (BBH)
Es liegen keine Finanzdaten für Vaneck Biotech Etf (BBH) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.40%
0.75%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):